tiprankstipranks

2seventy bio Delays Yearly Report Filing

Story Highlights
2seventy bio Delays Yearly Report Filing

2seventy bio ( (TSVT) ) has released a notification of late filing.

2seventy bio, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the time and resources required to negotiate a proposed acquisition by Bristol-Myers Squibb Company and to complete the company’s financial statement close and related reporting processes. The company anticipates filing the report within the fifteen-day extension period allowed by Rule 12b-25. There are no expected significant changes in financial results from the previous year, and the company is committed to maintaining compliance. The notification was signed by Victoria Eatwell, the Chief Financial Officer.

More about 2seventy bio

YTD Price Performance: 67.23%

Average Trading Volume: 1,010,960

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $255.4M

For an in-depth examination of TSVT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App